Home > Drug Search >
  • company_query: Argenes
  •   > 
Drug Filter
Category:
chemistry (16) biology (15)
Status:
Approved (4) NDA Filing (2) Phase Ⅲ (1) Phase Ⅱ (13) Phase Ⅰ (11)
Clinical Stage:
Pending (4) Active (21) Discontinued (2)
Bio-Type:
CAR T cell therapy (1) TCR therapy (1) Vaccine (6) Whole antibody (4)
Indication:
Acute lymphoblastic leukaemia (ALL) (1) Acute myeloid Leukemia (AML) (3) Allergic rhinoconjunctivitis (1) Breast cancer (1) Cancer related pain (1) Candidiasis (1) Chronic lymphocytic leukemia (CLL) (2) Chronic obstructive pulmonary disease (COPD) (1) Chronic pain (1) Glioblastoma multiforme (1) Dyskinesia (2) Influenza virus infection (1) Lung cancer (1) Lymphoma (2) Motion sickness (1) Myelodysplastic syndrome (MDS) (1) Non small cell lung cancer (NSCLC) (1) Non-Hodgkin B-cell lymphomas (1) Non-Hodgkin’s lymphoma (NHL) (2) Pancreatic cancer (1) Neuroprotection (1) Rheumatoid arthritis (RA) (1) Schizophrenia (2) Solid tumours (2) Systemic lupus erythematosus (1) Type 2 diabetes (1) Erythema (1) Colorectal cancer (1) Testicular cancer (1) Anthrax (1) Kaposi's sarcoma (1) Autoimmune diseases (3) Gram-positive bacterial infection (1) Gram-negative bacterial infection (1) Ewing's Sarcoma (1) Plaque psoriasis (1) Enterovirus infection (1) Brain cancer (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top